DMK PHARMACEUTICALS Corp Quarterly Revenues in USD from Q1 2018 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: DMK PHARMACEUTICALS Corp quarterly/annual Revenues history and growth rate from Q1 2018 to Q3 2023.
DMK PHARMACEUTICALS Corp Revenues for the quarter ending September 30, 2023 was $9.06K, a 99.4% decline year-over-year.
DMK PHARMACEUTICALS Corp Revenues for the twelve months ending September 30, 2023 was $3.53M, a 138% increase year-over-year.
DMK PHARMACEUTICALS Corp annual Revenues for 2022 was $4.76M, a 115% increase from 2021.
DMK PHARMACEUTICALS Corp annual Revenues for 2021 was $2.21M, a 20.5% decline from 2020.
DMK PHARMACEUTICALS Corp annual Revenues for 2020 was $2.78M, a 87.4% decline from 2019.

Revenues, Trailing 12 Months (USD)

Revenues, Quarterly (USD)

Revenues, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	$3.53M	$9.06K	-$1.5M	-99.4%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$5.02M	$6.95K	-$32.9K	-82.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-21
Q1 2023	$5.05M	$1.45M	+$298K	+25.9%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$4.76M	$2.06M	+$3.28M		Oct 1, 2022	Dec 31, 2022	10-K	2023-03-16
Q3 2022	$1.48M	$1.51M	+$746K	+98.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	$734K	$39.8K	-$1.24M	-96.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-21
Q1 2022	$1.97M	$1.15M	-$239K	-17.1%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$2.21M	-$1.22M	+$5.46M	+81.7%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-16
Q3 2021	-$3.25M	$760K	-$108K	-12.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$3.14M	$1.28M	-$2.65M	-67.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021	-$494K	$1.39M	-$3.27M	-70.1%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	$2.78M	-$6.68M	-$12.2M	-221%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-31
Q3 2020	$15M	$868K	-$5.03M	-85.3%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-22
Q2 2020	$20M	$3.93M	-$1.84M	-31.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-11-22
Q1 2020	$21.9M	$4.66M	-$243K	-4.94%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-11-22
Q4 2019	$22.1M	$5.54M	+$1.39M	+33.4%	Oct 1, 2019	Dec 31, 2019	10-K	2021-04-15
Q3 2019	$20.7M	$5.9M	+$2.07M	+54%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	$18.7M	$5.76M	+$1.84M	+47%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-17
Q1 2019	$16.8M	$4.91M	+$1.73M	+54.3%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-18
Q4 2018	$15.1M	$4.15M			Oct 1, 2018	Dec 31, 2018	10-K	2020-03-30
Q3 2018		$3.83M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018		$3.92M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018		$3.18M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.